Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 2 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bone Biologics Corporation | BBLG | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.5251 | 05:39:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.5251 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 2 | 2 | - | 1.46 - 72.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:26:26 | 1 | $ 1.52 | USD |
Bone Biologics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 817.38k | 534.24k | - | 0 | -8.95M | -16.75 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Bone Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BBLG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.74 | 1.94 | 1.46 | 1.65 | 55,440 | -0.2149 | -12.35% |
| 1 Month | 2.04 | 2.28 | 1.46 | 1.74 | 40,644 | -0.5149 | -25.24% |
| 3 Months | 3.57 | 4.74 | 1.46 | 2.51 | 85,707 | -2.04 | -57.28% |
| 6 Months | 4.40 | 10.56 | 1.46 | 5.53 | 598,527 | -2.87 | -65.34% |
| 1 Year | 60.552 | 72.00 | 1.46 | 15.88 | 539,699 | -59.03 | -97.48% |
| 3 Years | 1,140.00 | 1,709.256 | 1.46 | 479.19 | 483,278 | -1,138.47 | -99.87% |
| 5 Years | 1,140.00 | 1,709.256 | 1.46 | 479.19 | 483,278 | -1,138.47 | -99.87% |
Bone Biologics Description
| Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. |
